Introduction: Breast cancer (BC) is a heterogeneous group of diseases characterized by varied clinical, morphological, and genetic manifestations. In Brazil, it is the leading cause of cancer-related deaths among Black women and is associated with factors such as social status and structural racism. The lack of research on this group exacerbates the scarcity of information and public policies for healthcare access, particularly in the Northern Region. Objectives: To analyze breast cancer incidence in Black women in the Northern Region between 2014 and 2024. Methods: This is an observational, retrospective, quantitative, and document-based study. The research was conducted using data extracted from the Brazilian Unified Health System’s Informatics Department (DATASUS). Information on BC incidence in Black women in the Northern Region was analyzed, including year of diagnosis, age group, mortality, geographic distribution, and age-related trends. Results: During the study period, 560 cases of breast cancer were analyzed in this population. The year with the highest number of cases was 2024 (21.4%, 120 cases), followed by 2023 (10.5%), 2022 (10.3%), 2021 (9%), 2020 (8.5%), 2015 (8.2%), 2014 (8.3%), 2019 and 2018 (6.9% each), 2016 (5.7%), and 2017 (4.1%). The most affected age groups were 50–59 years (167 cases) and 40–49 years (160 cases). The states of Pará and Rondônia had the highest number of cases (201 and 140, respectively). Additionally, the highest mortality rates occurred in Pará (37.2%) and Rondônia (18.6%). Conclusion: The analysis revealed a significant 166% increase in BC cases among Black women, particularly in the 50–59 age group. This age profile suggests late diagnoses and insufficient mammography coverage. Furthermore, Pará had the highest proportional concentration of cases, indicating regional disparities and a lack of public health policies. The findings highlight the need to understand not only the rising incidence and regional-age patterns but also to address racial health inequities. This population requires greater access to information, prevention, and screening. Future research should further explore this topic to guide targeted interventions, as there is a clear need to revise early detection strategies and improve access to timely diagnosis and treatment in the Northern Region.
It is with great enthusiasm that we present the Annals of the Oncology International Symposium 2025, an event that continues to solidify its significance in the oncology landscape of northern Brazil. Held in Belém, Pará, Oncology 2025 centered around the theme "The cancer control challenge: better knowing it to best facing it," dedicating itself to exploring the latest frontiers in cancer treatment and prevention.
This year, the symposium provided a deep dive into the essential role of knowledge in the fight against cancer, presenting new perspectives and scientific advancements across various areas of oncology. Renowned global experts gathered to share their most recent research and innovative approaches, offering participants a comprehensive view of the challenges faced by healthcare professionals and patients worldwide.
Presentations and discussions during the event focused on critical topics such as the use of new technologies, advancements in personalized therapies, and more effective prevention strategies. Additionally, particular attention was given to the unique challenges faced by the Amazon region, with efforts aimed at developing region-specific solutions to meet local needs.
Beyond being a high-caliber academic event, Oncology 2025 stood out as a moment for integration and professional networking, with the warm hospitality of the city of Belém offering participants a unique experience. This event became a platform for exchanging ideas, where science, culture, and humanity came together in pursuit of a common goal: to improve cancer control both in Brazil and globally.
This collection of abstracts and articles presented during the event reflects the ongoing dedication to research and the development of innovative solutions, highlighting the importance of collaboration and shared knowledge in the fight against cancer.
General Submission Guidelines:
The presenting author, who does not have to be the first author, must be registered for Oncology 2025.
Each abstract may have up to 10 authors, including the main author and co-authors.
Only original, unpublished work will be accepted.
Submissions must be related to oncology. However, project descriptions, work proposals, experience reports, and literature reviews will not be considered.
Clinical case reports are allowed, provided the abstract addresses scientific questions, details clinical observations, and includes primary scientific data.
The abstract must be written in English, but presentations may be given in Portuguese.
Abstracts must be between 300 and 500 words.
Comissão Organizadora
Comissão Científica
See Annals of Oncology 2023 at:
https://www.even3.com.br/anais/oncology-2023-international-symposium/
Complete tool for submission, evaluation and publication of proceedings for scientific events.
